De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis
ConclusionsThese data are supportive of de-escalation of zoledronate from onset for patients with bone metastases from breast cancer.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Conferences | Statistics | Study | Xgeva